With over 15 years of leadership in contract process development and manufacturing, AGC Biologics offers a deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics. The company’s 850 dedicated employees are committed to providing solutions for more than 100 customers on five continents. Headquartered in Seattle, AGC’s integrated service offerings include, amongst other things, cell line and bioprocess development, antibody drug development and conjugation, and protein expression.